Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23420608 | 0.94 | NAAA (0.51) | TSHRHPGDNAAAALDH1A1DNM1 | |
| SCHEMBL20125937 | 0.94 | NAAA (0.51) | TSHRHPGDNAAAALDH1A1DNM1 | |
| SCHEMBL20125897 | 0.90 | CA12 (0.41) | TSHRHPGDNAAAALDH1A1DNM1 | |
| SCHEMBL20125957 | 0.84 | TSHR (0.50) | TSHRHPGDATMNAAAALDH1A1 | |
| SCHEMBL20126042 | 0.83 | DNM1 (0.50) | TSHRHPGDATMNAAAALDH1A1 | |
| SCHEMBL20125982 | 0.82 | CA12 (0.56) | TSHRHPGDALDH1A1CA12CA1 | |
| SCHEMBL20128242 | 0.82 | TSHR (0.51) | TSHRHPGDATMNAAAALDH1A1 | |
| SCHEMBL20126059 | 0.81 | TSHR (0.50) | TSHRHPGDATMNAAAALDH1A1 | |
| SCHEMBL20125941 | 0.81 | TSHR (0.50) | TSHRHPGDATMNAAAALDH1A1 | |
| SCHEMBL20126060 | 0.80 | TSHR (0.49) | TSHRHPGDATMNAAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12286491-B2 | Image forming device and image forming method | RICOH COMPANY, LTD. (JP) | 2025-04-29 | — | — | US | disclosed |
| CN-112469306-B | Composition, artificial nail composition, nail decorating material, artificial nail, storage container, image forming apparatus, and image forming method | 株式会社理光 | 2024-07-05 | — | — | CN | disclosed |
| EP-4208261-A1 | USE OF SOS1 INHIBITORS TO TREAT MALIGNANCIES WITH SHP2 MUTATIONS | Revolution Medicines, Inc. (US) | 2023-07-12 | — | — | EP | disclosed |
| US-20230135413-A1 | CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230135413-A1 | CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230077371-A1 | CURABLE COMPOSITION, CURABLE INK, COMPOSITION CONTAINER, DEVICE FOR FORMING TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE, METHOD OF FORMING TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE, CURED MATTER, AND DECORATIVE OBJECT | RICOH COMPANY, LTD. (JP) | 2023-03-16 | — | — | US | disclosed |
| US-11529302-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2022-12-20 | — | — | US | disclosed |
| US-11479622-B2 | Active energy ray curable composition, active energy ray curable ink, composition accommodating container, two or three dimensional image forming apparatus, two or three dimensional image forming method, cured matter, decorative matter, artificial nail composition, nail decorative material, and artificial nail | RICOH COMPANY, LTD. (JP) | 2022-10-25 | — | — | US | disclosed |
| US-20220259338-A1 | IMAGE FORMING DEVICE AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2022-08-18 | — | — | US | disclosed |
| WO-2022060583-A1 | USE OF SOS1 INHIBITORS TO TREAT MALIGNANCIES WITH SHP2 MUTATIONS | Revolution Medicines, Inc. (US) | 2022-03-24 | — | — | WO | disclosed |
| US-20200038310-A1 | COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2020-02-06 | — | — | US | disclosed |
| US-20200032089-A1 | COMPOSITION, CURED PRODUCT, STORAGE CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2020-01-30 | — | — | US | disclosed |
| US-20200032068-A1 | COMPOSITION, CURED PRODUCT, STORAGE CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2020-01-30 | — | — | US | disclosed |
| US-20200031969-A1 | COMPOSITION, CURED PRODUCT, STORAGE CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2020-01-30 | — | — | US | disclosed |
| US-20200031969-A1 | COMPOSITION, CURED PRODUCT, STORAGE CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2020-01-30 | — | — | US | disclosed |
| US-20190284409-A1 | COMPOSITION, CURED PRODUCT, COMPOSITION STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2019-09-19 | — | — | US | disclosed |
| US-20190023924-A1 | COMPOSITION, CURED PRODUCT, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2019-01-24 | — | — | US | disclosed |
| EP-3431557-A1 | COMPOSITION, CURED PRODUCT, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | Ricoh Company, Limited (JP) | 2019-01-23 | — | — | EP | disclosed |
| US-20180127607-A1 | CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND | RICOH COMPANY, LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-20180127607-A1 | CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND | RICOH COMPANY, LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127607-A1 | CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND | CRYAA, CDKN1A, ACR | TSHR 4587/4885HPGD 3636/4885ATM 295/4885 |
| US-20200038310-A1 | COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | NACA, PIK3C3, ACR | TSHR 1730/4885HPGD 4478/4885ATM 722/4885 |
| US-11529302-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | NACA, PIK3C3, ACR | TSHR 1730/4885HPGD 4478/4885ATM 722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.